Efficacy and safety of alogliptin added to sulfonylurea in Japanese patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial with an open‐label, long‐term extension study

類似資料

• Glucagon‐like peptide‐1 analog liraglutide in combination with sulfonylurea safely improves blood glucose measures vs sulfonylurea monotherapy in Japanese patients with type 2 diabetes: Results of a 52‐week, randomized, multicenter trial
  著者:: Seino, Yutaka, 等
  出版事項: (2011)
• Randomized, double‐blind, phase III study to evaluate the efficacy and safety of once‐daily treatment with alogliptin and metformin hydrochloride in Japanese patients with type 2 diabetes
  著者:: Kaku, Kohei, 等
  出版事項: (2017)
• Controversy about the relationship between sulfonylurea use and cardiovascular events and mortality
  著者:: Shimoda, Masashi, 等
  出版事項: (2016)
• A randomized, placebo‐controlled study to evaluate the efficacy and safety of adding omarigliptin to insulin therapy in Japanese patients with type 2 diabetes and inadequate glycaemic control
  著者:: Kadowaki, Takashi, 等
  出版事項: (2021)
• Combination therapy with liraglutide and insulin in Japanese patients with type 2 diabetes: A 36‐week, randomized, double‐blind, parallel‐group trial
  著者:: Seino, Yutaka, 等
  出版事項: (2016)